0969.HK
Hua Lien International (Holding) Company Limited [0969.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0969.HK Stock Summary
In the News
0969.HK Financial details
Company Rating
Strong Sell
Market Cap
350.59M
Income
-74.35M
Revenue
285.13M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
142
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
-6.87
Forward P/E
-
PEG
-0.55
P/S
2.15
P/B
-0.36
P/C
-
P/FCF
-6.56
Quick Ratio
0.04
Current Ratio
0.09
Debt / Equity
-0
LT Debt / Equity
-
-
-
EPS (TTM)
-0.03
EPS next Y
-
EPS next Q
-
EPS this Y
24.5%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-14.81%
Revenue last 5Y
0.98%
Revenue Q/Q
-27.3%
EPS Q/Q
200%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-42%
ROE
5%
ROC
0.01%
Gross Margin
15%
Oper. Margin
-9%
Profit Margin
-31%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.112-0.21
52W High
-
52W Low
-
RSI
50
Rel Volume
1.68
Avg Volume
13.13K
Volume
22K
Perf Week
-5.66%
Perf Month
-3.23%
Perf Quarter
-
Perf Half Y
-3.23%
-
-
-
-
Beta
0.077
-
-
Volatility
0.01%, 0.01%
Prev Close
0%
Price
0.15
Change
0%
0969.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.06 | 0.05 | 0.06 | 0.07 | 0.06 | |
| Net income per share | -0.04 | -0.04 | -0.02 | -0.02 | -0.02 | |
| Operating cash flow per share | 0 | 0 | 0.01 | -0.02 | 0 | |
| Free cash flow per share | 0 | 0 | 0.01 | -0.02 | 0 | |
| Cash per share | 0.03 | 0.03 | 0.04 | 0.02 | 0.02 | |
| Book value per share | -0.34 | -0.37 | -0.37 | -0.39 | -0.41 | |
| Tangible book value per share | -0.61 | -0.45 | -0.45 | -0.48 | -0.5 | |
| Share holders equity per share | -0.34 | -0.37 | -0.37 | -0.39 | -0.41 | |
| Interest debt per share | 0.25 | 0.26 | 0.26 | 0.29 | 0.01 | |
| Market cap | 157.76M | 127.09M | 133.66M | 416.32M | 372.5M | |
| Enterprise value | 613.06M | 601.98M | 613M | 979.91M | 360.74M | |
| P/E ratio | -1.72 | -1.32 | -4.03 | -12.56 | -9.04 | |
| Price to sales ratio | 1.16 | 1.07 | 0.99 | 2.91 | 2.62 | |
| POCF ratio | -911.94 | 30.88 | 8.59 | -9.39 | 0 | |
| PFCF ratio | -46.98 | 35.71 | 9.32 | -8.92 | 0 | |
| P/B Ratio | -0.21 | -0.16 | -0.16 | -0.49 | -0.42 | |
| PTB ratio | -0.21 | -0.16 | -0.16 | -0.49 | -0.42 | |
| EV to sales | 4.52 | 5.08 | 4.52 | 6.86 | 2.54 | |
| Enterprise value over EBITDA | -14.1 | -19.71 | 30.41 | -89.71 | -73.39 | |
| EV to operating cash flow | -3.54K | 146.29 | 39.4 | -22.1 | 0 | |
| EV to free cash flow | -182.57 | 169.14 | 42.77 | -20.99 | 0 | |
| Earnings yield | -0.58 | -0.76 | -0.25 | -0.08 | -0.11 | |
| Free cash flow yield | -0.02 | 0.03 | 0.11 | -0.11 | 0 | |
| Debt to equity | -0.7 | -0.66 | -0.69 | -0.71 | 0 | |
| Debt to assets | 2.46 | 4.07 | 3.71 | 5.68 | 0.02 | |
| Net debt to EBITDA | -10.47 | -15.55 | 23.78 | -51.6 | 2.39 | |
| Current ratio | 0.18 | 0.11 | 0.13 | 0.09 | 0.07 | |
| Interest coverage | -1.33 | -1.32 | 0.94 | -0.56 | -0.29 | |
| Income quality | 0 | -0.04 | -0.47 | 1.34 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.31 | 0.25 | 0.21 | 0.23 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 2 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 18.41 | -0.14 | -0.08 | 0.05 | 0 | |
| Capex to revenue | -0.02 | 0 | -0.01 | -0.02 | 0 | |
| Capex to depreciation | -1.17 | -0.29 | -0.93 | -1.79 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.57 | 0.6 | 0.36 | 0.36 | 0.41 | |
| ROIC | 0.17 | 0.1 | -0.05 | 0.04 | 0.01 | |
| Return on tangible assets | 0.43 | -0.73 | -0.22 | -0.31 | -0.48 | |
| Graham Net | -0.44 | -0.47 | -0.47 | -0.5 | -0.52 | |
| Working capital | -891.74M | -969.09M | -971.43M | -1.04B | -1.08B | |
| Tangible asset value | -1.33B | -985.16M | -988.95M | -1.05B | -1.1B | |
| Net current asset value | -916.91M | -993.12M | -995.64M | -1.06B | -1.11B | |
| Invested capital | -0.7 | -0.66 | -0.69 | -0.71 | 0 | |
| Average receivables | 60.77M | 28.1M | 6.48M | 4.2M | 2.61M | |
| Average payables | 19.91M | 17.43M | 10.15M | 8.18M | 6.18M | |
| Average inventory | 95.71M | 65.65M | 52.26M | 53.96M | 45.64M | |
| Days sales outstanding | 130.86 | 23.43 | 14.43 | 7.79 | 5.55 | |
| Days payables outstanding | 68.16 | 43.31 | 30.79 | 20.25 | 16.89 | |
| Days of inventory on hand | 235.46 | 193.64 | 181.88 | 153.42 | 120.96 | |
| Receivables turnover | 2.79 | 15.58 | 25.3 | 46.88 | 65.73 | |
| Payables turnover | 5.35 | 8.43 | 11.85 | 18.02 | 21.61 | |
| Inventory turnover | 1.55 | 1.88 | 2.01 | 2.38 | 3.02 | |
| ROE | 0.12 | 0.12 | 0.04 | 0.04 | 0.05 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.03 | 0.04 | 0.03 | 0.04 | 0 | |
| Net income per share | -0.01 | 0 | -0.02 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | -0.02 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | -0.02 | 0 | 0 | |
| Cash per share | 0.04 | 0.03 | 0.02 | 0.02 | 0 | |
| Book value per share | -0.37 | -0.38 | -0.39 | -0.39 | 0 | |
| Tangible book value per share | -0.45 | -0.46 | -0.48 | -0.48 | 0 | |
| Share holders equity per share | -0.37 | -0.38 | -0.39 | -0.39 | 0 | |
| Interest debt per share | 0.26 | 0.27 | 0.28 | 0.29 | 0 | |
| Market cap | 133.66M | 122.71M | 416.32M | 403.18M | 0 | |
| Enterprise value | 613M | 621.35M | 979.91M | 980.69M | -11.77M | |
| P/E ratio | -1.72 | -297.83 | -3.15 | -9.81 | 0 | |
| Price to sales ratio | 2.3 | 1.52 | 6.71 | 4.89 | 0 | |
| POCF ratio | 14.36 | -20.33 | -10.87 | 122.03 | 0 | |
| PFCF ratio | 14.34 | -14.1 | -10.96 | 342.26 | 0 | |
| P/B Ratio | -0.16 | -0.15 | -0.49 | -0.47 | 0 | |
| PTB ratio | -0.16 | -0.15 | -0.49 | -0.47 | 0 | |
| EV to sales | 10.55 | 7.69 | 15.79 | 11.9 | -0.2 | |
| Enterprise value over EBITDA | 60.93 | 861.79 | -84.19 | 55.83 | 0.52 | |
| EV to operating cash flow | 65.86 | -102.94 | -25.58 | 296.82 | 0 | |
| EV to free cash flow | 65.77 | -71.39 | -25.8 | 832.5 | 0 | |
| Earnings yield | -0.15 | 0 | -0.08 | -0.03 | 0 | |
| Free cash flow yield | 0.07 | -0.07 | -0.09 | 0 | 0 | |
| Debt to equity | -0.69 | -0.69 | -0.71 | -0.72 | 0 | |
| Debt to assets | 3.71 | 4.19 | 5.68 | 5.08 | 0.02 | |
| Net debt to EBITDA | 47.64 | 691.6 | -48.42 | 32.88 | 0.52 | |
| Current ratio | 0.13 | 0.12 | 0.09 | 0.1 | 0.07 | |
| Interest coverage | 0.95 | -0.04 | -1.04 | 1.32 | -2.48 | |
| Income quality | -0.48 | 58.6 | 1.16 | -0.32 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.24 | 0.17 | 0.31 | 0.15 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0.44 | -0.01 | -0.64 | 0 | |
| Capex to revenue | 0 | -0.03 | 0.01 | -0.03 | 0 | |
| Capex to depreciation | 0.04 | -2.28 | 2.39 | -1.94 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.27 | 0.02 | 0.36 | 0.2 | 0 | |
| ROIC | -0.02 | 0 | 0.04 | -0.05 | 0.02 | |
| Return on tangible assets | -0.13 | 0 | -0.31 | -0.08 | -0.36 | |
| Graham Net | -0.47 | -0.48 | -0.5 | -0.5 | 0 | |
| Working capital | -971.43M | -991.19M | -1.04B | -1.04B | -1.08B | |
| Tangible asset value | -988.95M | -1.01B | -1.05B | -1.06B | -1.1B | |
| Net current asset value | -995.64M | -1.01B | -1.06B | -1.07B | -1.11B | |
| Invested capital | -0.69 | -0.69 | -0.71 | -0.72 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 8.31 | 5.35 | 4.42 | 4.4 | 3.25 | |
| Days payables outstanding | 14.43 | 6.72 | 11.13 | 18.98 | 7.45 | |
| Days of inventory on hand | 85.26 | 68.46 | 84.32 | 111.55 | 53.38 | |
| Receivables turnover | 10.84 | 16.82 | 20.37 | 20.45 | 27.67 | |
| Payables turnover | 6.24 | 13.38 | 8.09 | 4.74 | 12.07 | |
| Inventory turnover | 1.06 | 1.31 | 1.07 | 0.81 | 1.69 | |
| ROE | 0.02 | 0 | 0.04 | 0.01 | 0.03 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
0969.HK Frequently Asked Questions
What is Hua Lien International (Holding) Company Limited stock symbol ?
Hua Lien International (Holding) Company Limited is a HK stock and trading under the symbol 0969.HK
What is Hua Lien International (Holding) Company Limited stock quote today ?
Hua Lien International (Holding) Company Limited stock price is $0.15 today.
Is Hua Lien International (Holding) Company Limited stock public?
Yes, Hua Lien International (Holding) Company Limited is a publicly traded company.
Company Profile
- Volume Average 13.13K
- Market Capitalization 350.59M
- Employee 142
- CEO Mr. Hong Han
- Headquarters Central,HK
- IPO Date 2000-02-02
-
Website
https://www.irasia.com/listco/hk/hualien/index.htm 
Hua Lien International (Holding) Company Limited, an investment holding company, engages in the cultivation of sugar cane, and manufacturing of sugar businesses. It operates through Supporting Services, Sugar Business, and Ethanol Business segments. The company is also involved in the provision of supporting services to customers in the sweetener and ethanol business; and ethanol biofuel business. It operates in Jamaica and the United States. The company was incorporated in 1999 and is based in Central, Hong Kong.
